Filter News
Area of Research
- (-) Computer Science (1)
- (-) Isotopes (4)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (34)
- Clean Energy (46)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (7)
- Fusion Energy (1)
- Materials (27)
- Materials for Computing (5)
- National Security (19)
- Neutron Science (13)
- Nuclear Science and Technology (7)
- Supercomputing (49)
News Topics
- (-) Biomedical (4)
- (-) Machine Learning (1)
- Artificial Intelligence (1)
- Climate Change (1)
- Computer Science (5)
- Cybersecurity (1)
- Energy Storage (1)
- Environment (1)
- Isotopes (21)
- Materials (3)
- Materials Science (3)
- National Security (1)
- Nuclear Energy (3)
- Quantum Science (2)
- Security (1)
- Space Exploration (3)
Media Contacts
![Seeing the difference Ac-225 could make to cancer patients made Raina Setzer want to come to ORNL to directly work with the isotope. Credit: Allison Peacock/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-11/rs_0.jpg?h=71976bb4&itok=nFsgqwUT)
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
![Catherine Schuman during Hour of Code](/sites/default/files/styles/list_page_thumbnail/public/2019-12/IMG_0136_0.jpg?h=71976bb4&itok=56CtnbAH)
ORNL computer scientist Catherine Schuman returned to her alma mater, Harriman High School, to lead Hour of Code activities and talk to students about her job as a researcher.